Multicenter Analysis of Clinical Follow-Ups in Patients with a Star GK Cardiac Valve Replacement for More than One Year

Authors

  • Mingwen Li Department of Cardiovascular Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing
  • Yingbin Xiao Department of Cardiovascular Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing
  • Daozhong Chen Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou
  • Liming Liu Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha
  • Liming Ma Department of Cardiovascular Surgery, Affiliated Hospital of Jining Medical University, Jining
  • Pingfan Wang Department of Cardiovascular Surgery, Henan Provincial Chest Hospital, Zhengzhou
  • Kui Jia The First Affiliated Hospital of Nanyang Medical College, Nanyang
  • Kai Yang Department of Cardiovascular Surgery, Nanyang City Center Hospital, Nanyang
  • Lin Chen Department of Cardiovascular Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing

DOI:

https://doi.org/10.1532/hsf.1441

Abstract

Background: Star GK valves were widely used in China, and we studied the clinical follow-up results of patients with Star GK valve implants for more than one year. 

Methods: Clinical data were collected from those patients who had Star GK valve implants for over one year. Patients were divided into three groups: (1) AVR group: received aortic valve replacement surgery. Based on the valve model this group was further sub-divided into two groups: 21A group, and 23A group; (2) MVR group: received mitral valve replacement surgery. Based on the valve model this group was further sub-divided into three groups: 25M group, 27M group, and 29M group; (3) DVR group: received combined replacement surgeries including AVR + MVR. According to postoperative follow-up time these patients were divided into two groups: 1-year group and 3-year group. Follow-up data were collected by telephone, outpatient visits, or correspondence. Clinical data were aggregated by professional data scientists to conduct independent analyses. 

Results: 959 patients were included in the study following Star GK valve implant. Follow-up after 1 year found that thrombosis occurred in 4 cases, hemorrhage in 15 cases, left heart failure in 13 cases, paravalvular leakage in 5 cases, and death due to cardiac causes in 2 cases. 

Conclusion: The long-term efficacy of Star GK valve implants was satisfactory with low incidence of valve-related complications, and following Star GK valve implant, valve and blood were highly compatible and blood component damage was minor. Very low incidence rate of thrombosis was observed following Star GK valve implant, however, attention should be paid to adjust the anticoagulation intensity. 

References

Blauwet LA, Malouf JF, Connolly HM, et al. 2007. Doppler echocardiography of 79 normal CarboMedics mitral prostheses: a comprehensive assessment including time-velocity integral ratio and prosthesis performance index. J Am Soc Echocardiogr 20:1125-30.

Gillinov AM, Blackstone EH, Rodriguez LL. 2003. Prosthesis patient size: measurement and clinical implications. J Thorac Cardiovasc Surg 126:313-16.

Kaneko T, Aranki S, Javed Q, et al. 2014. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. J Thorac Cardiovasc Surg 147:117-26.

McCarthy PM, Kruise J, Shalli S, et al. 2010. Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation. J Thorac Cardiovas Surg 139:860-7.

Moraca RJ, Moon MR, Lawton JS, et al. 2009. Outcomes of tricuspid valve repair and replacement: A propensity analysis. Ann Thorac Surg 87:83-9.

Pibarot P, Magne J, Dumesnil JG. 2008. Prosthesis-patient mismatch after mitral valve replacement: back to reality. J Thorac Cardiovasc Surg 135:464-5.

Reid A, Ray S. 2014. Mitral and tricuspid valve disease. Medicine 42:632-7.

Sims JB, Roberts WC. 2006. Comparison of findings in patients with versus without atrial fibrillation just before isolated mitral valve replacement for rheumatic mitral stenosis. Am J Cardiol 97:1035-8.

Published

2016-05-18

How to Cite

Li, M., Xiao, Y., Chen, D., Liu, L., Ma, L., Wang, P., Jia, K., Yang, K., & Chen, L. (2016). Multicenter Analysis of Clinical Follow-Ups in Patients with a Star GK Cardiac Valve Replacement for More than One Year. The Heart Surgery Forum, 19(3), E104-E109. https://doi.org/10.1532/hsf.1441

Issue

Section

Article